Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 30, 2025 • 6:31 PM ET

Date/Time Source News Release
07/28/2025 07:00 AM EDT PR Newswire Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resistant Ovarian Cancer at ESMO 2025
07/23/2025 07:00 AM EDT PR Newswire Compugen to Release Second Quarter 2025 Results on Wednesday, August 6, 2025
07/21/2025 07:00 AM EDT PR Newswire Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Platinum Sensitive Ovarian Cancer
06/12/2025 07:00 AM EDT PR Newswire Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences
05/19/2025 07:00 AM EDT PR Newswire Compugen Reports First Quarter 2025 Results
05/13/2025 07:00 AM EDT PR Newswire Compugen Announces Leadership Transitions Effective September 2025
05/05/2025 07:00 AM EDT PR Newswire Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025
03/26/2025 07:00 AM EDT PR Newswire Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
03/04/2025 08:15 AM EST PR Newswire /C O R R E C T I O N -- Compugen Ltd./
03/04/2025 07:00 AM EST PR Newswire Compugen Reports Fourth Quarter and Full Year 2024 Results
Page